Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa

A phase III, double-blind, randomized, controlled trial (NCT00866619) in sub-Saharan Africa showed RTS,S/AS01 vaccine efficacy against malaria. We now present in-depth safety results from this study. 8922 children (enrolled at 5–17 months) and 6537 infants (enrolled at 6–12 weeks) were 1:1:1-randomi...

詳細記述

保存先:
書誌詳細
出版年:Hum Vaccin Immunother
主要な著者: Guerra Mendoza, Yolanda, Garric, Elodie, Leach, Amanda, Lievens, Marc, Ofori-Anyinam, Opokua, Pirçon, Jean-Yves, Stegmann, Jens-Ulrich, Vandoolaeghe, Pascale, Otieno, Lucas, Otieno, Walter, Owusu-Agyei, Seth, Sacarlal, Jahit, Masoud, Nahya Salim, Sorgho, Hermann, Tanner, Marcel, Tinto, Halidou, Valea, Innocent, Mtoro, Ali Takadir, Njuguna, Patricia, Oneko, Martina, Otieno, Godfrey Allan, Otieno, Kephas, Gesase, Samwel, Hamel, Mary J, Hoffman, Irving, Kaali, Seyram, Kamthunzi, Portia, Kremsner, Peter, Lanaspa, Miguel, Lell, Bertrand, Lusingu, John, Malabeja, Anangisye, Aide, Pedro, Akoo, Pauline, Ansong, Daniel, Asante, Kwaku Poku, Berkley, James A, Adjei, Samuel, Agbenyega, Tsiri, Agnandji, Selidji Todagbe, Schuerman, Lode
フォーマット: Artigo
言語:Inglês
出版事項: Taylor & Francis 2019
主題:
Research Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6816384/
https://ncbi.nlm.nih.gov/pubmed/31012786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1586040
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料